GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (LTS:0GTN) » Definitions » Cyclically Adjusted FCF per Share

BioGaia AB (LTS:0GTN) Cyclically Adjusted FCF per Share : kr2.42 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is BioGaia AB Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

BioGaia AB's adjusted free cash flow per share for the three months ended in Dec. 2023 was kr1.068. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr2.42 for the trailing ten years ended in Dec. 2023.

During the past 12 months, BioGaia AB's average Cyclically Adjusted FCF Growth Rate was 16.30% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 9.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 8.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of BioGaia AB was 9.90% per year. The lowest was 6.10% per year. And the median was 7.80% per year.

As of today (2024-04-30), BioGaia AB's current stock price is kr115.50. BioGaia AB's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was kr2.42. BioGaia AB's Cyclically Adjusted Price-to-FCF of today is 47.73.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of BioGaia AB was 74.34. The lowest was 39.18. And the median was 48.93.


BioGaia AB Cyclically Adjusted FCF per Share Historical Data

The historical data trend for BioGaia AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGaia AB Cyclically Adjusted FCF per Share Chart

BioGaia AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.67 1.83 2.01 2.11 2.42

BioGaia AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.11 2.20 2.24 2.31 2.42

Competitive Comparison of BioGaia AB's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioGaia AB's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where BioGaia AB's Cyclically Adjusted Price-to-FCF falls into.



BioGaia AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioGaia AB's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.068/130.9575*130.9575
=1.068

Current CPI (Dec. 2023) = 130.9575.

BioGaia AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 1.306 99.788 1.714
201406 0.195 100.432 0.254
201409 -0.177 100.161 -0.231
201412 -0.115 100.225 -0.150
201503 0.437 99.950 0.573
201506 0.276 99.995 0.361
201509 0.193 100.228 0.252
201512 0.128 100.276 0.167
201603 0.379 100.751 0.493
201606 0.134 101.019 0.174
201609 0.601 101.138 0.778
201612 0.526 102.022 0.675
201703 0.893 102.022 1.146
201706 0.146 102.752 0.186
201709 0.436 103.279 0.553
201712 0.784 103.793 0.989
201803 0.459 103.962 0.578
201806 0.317 104.875 0.396
201809 0.833 105.679 1.032
201812 0.360 105.912 0.445
201903 0.358 105.886 0.443
201906 0.259 106.742 0.318
201909 0.611 107.214 0.746
201912 0.025 107.766 0.030
202003 0.798 106.563 0.981
202006 0.354 107.498 0.431
202009 0.599 107.635 0.729
202012 0.553 108.296 0.669
202103 0.405 108.360 0.489
202106 0.543 108.928 0.653
202109 0.655 110.338 0.777
202112 0.527 112.486 0.614
202203 0.871 114.825 0.993
202206 0.777 118.384 0.860
202209 0.423 122.296 0.453
202212 0.907 126.365 0.940
202303 0.962 127.042 0.992
202306 0.792 129.407 0.801
202309 0.892 130.224 0.897
202312 1.068 130.958 1.068

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


BioGaia AB  (LTS:0GTN) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

BioGaia AB's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=115.50/2.42
=47.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of BioGaia AB was 74.34. The lowest was 39.18. And the median was 48.93.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


BioGaia AB Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of BioGaia AB's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


BioGaia AB (LTS:0GTN) Business Description

Industry
Traded in Other Exchanges
Address
Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.

BioGaia AB (LTS:0GTN) Headlines

No Headlines